Dongying Zhang
1 Youyi Rd
Youyi, China
Youyi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Vericiguat for heart failure with reduced ejection fraction: a perspective from approval to real-world clinical treatment.
Journal: Expert review of cardiovascular therapy
Published: June 29, 2026
Efficacy of Vericiguat in Acute Heart Failure: A Target Trial Emulation Study.
Journal: Journal of the American Heart Association
Published: March 18, 2026
Clonal hematopoiesis of indeterminate potential is associated with increased cardiovascular risk in chronic kidney disease.
Journal: Clinical kidney journal
Published: November 02, 2025
Effects of SGLT2 Inhibitor in Patients with Diabetes with Newly Diagnosed Acute Myocardial Infarction: A Multicenter Prospective Cohort Study.
Journal: Cardiovascular drugs and therapy
Published: April 30, 2025
NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction.
Journal: Life sciences
Published: August 08, 2023
Association Between Visceral Fat, Blood Pressure and Arterial Stiffness in Patients with HFpEF: A Mediation Analysis.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: December 19, 2022
Gpx3 and Egr1 Are Involved in Regulating the Differentiation Fate of Cardiac Fibroblasts under Pressure Overload.
Journal: Oxidative medicine and cellular longevity
Published: March 13, 2022
EAT Thickness as a Predominant Feature for Evaluating Arterial Stiffness in Patients with Heart Failure with Preserved Ejection Fraction.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: December 29, 2021
Impact of Brachial-Ankle Pulse Wave Velocity on Myocardial Work by Non-invasive Left Ventricular Pressure-Strain in Non-hypertensive and Hypertensive Patients With Preserved Left Ventricular Ejection Fraction.
Journal: Frontiers in cardiovascular medicine
Published: November 16, 2021
Corrigendum to "MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21".
Journal: Mediators of inflammation
Published: August 14, 2021
Last Updated: 09/26/2026